Articles On Genetic Technologies (ASX:GTG)

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

After rallying back from -0.5% all day, the ASX finished basically flat, -0.06% from break-even Financials sucked but the rest of the market did well, and gold hit a record high above AUD$3,000/oz Lithium explorer Greenwing posts an unexp...

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The S&P ASX 200 closed up 0.2%, while the S&P XEC fell 0.61% Polymetal Resources soars 64% after announcing thick high grade drill hits at Endeavour polymetallic mine XTEK subsidiary HighCom Armour Solutions signs a collaboration d...

ASX was poised to finish flat, but managed to squeeze out a 1.2 point jump at the bell Goldies have soared again, thanks to spot gold prices rising back above US$2000 an ounce Western Mines Group defies the odds, cranking out a 186% rocket...

The ASX jumped 0.3% after lunch as the RBA finally kept rates on hold. XGD All Ordinaries Gold soared ~3.0% because someone missed a memo. Besra Gold is back on top with a 36% leap after Quantum’s cheque cleared customs.   Local markets w...

ASX closes up 0.78%, while XEC rises 1.91% following global markets higher Morningstar warns of possible start of US recession next week spanning 3 quarters, but talk of pause in Aussie rate hikes ‘premature’ Hubify subsidiary Broadland So...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX 200 was up 0.23% while the ASX XEC managed a 0.092% gain 8 out of 11 sectors were higher with Materials leading the way  The Real Estate sector was the weakest, down 0.77%   The ASX 200 was up 0.23% today while the ASX XEC squeez...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ImpediMed surges as the US NCCN included bioimpedance spectroscopy (BIS) as part new guidelines ImpediMed has the only FDA-cleared BIS technology for the assessment of lymphoedema GTG adds 3 new diseases to its geneType Multi-Test   Imped...

ASX down, then up, then down even further to -1.4% as bank crisis looms large. XEC Emerging Companies index plummets 1.8% as fear overtakes greed. Goldies are making hay again, XED All Ordinaries Gold up more than 7.0%.   Things have been...

The ASX bounced back from the week’s drama to close up by 0.86% The XEC Emerging Companies Index closed 1.26% higher because it’s young and needed the money Former PM Paul Keating kicks a glorious own goal at the Australian Press Club   H...

ASX weathers a US bank collapse storm to finish the day down just 0.5% XEC Emerging Companies index down 0.84% because it was out partying all weekend. The Goldies take the gongs, after the precious metal jumped more than 1.0%   Looking a...

Neuren Pharma gets a ‘historic’ FDA approval for DAYBUE to treat Rett syndrome Genetic Technologies published another research paper HITIQ sells 200 Nexus Head Impact Sensors to Monash University   Neuren Pharmaceuticals (ASX:NEU) surged...

ASX 200 adds just 0.1% because it was literally the least it could do. Aussie tech stock surge negated by Doctors and Miners having a bad hair day. Two ASX-listed lithium players are under attack over alleged corruption in Africa, of all p...

Stockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX scuttled by bleak rates outlook in the US, down 0.83% for the day RBA boss Philip Lowe had better news for Aussies. Kind of Summit Resources galloped to a win, up 35% on great REE news at Stallion   We have comments from US Fed chair...

The ASX spikes on ‘news’ that the RBA has pushed rates up again, closing at +0.6% Invocare has risen from the grave after a bit to buy up the funeral company China finally breaks Errol Flynn’s world record for rattling sabres, terrifying K...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Highlights Imugene has advanced its ongoing Phase 1 MAST study with the first patients receiving dosing in the intratumoral (IT) and intravenous (IV) cohorts of CF33-hNIS in combination with Pembrolizumab. The study is focused on measu...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX got an Data Nerd Bailout when the ABS dropped happy-ish CPI data The benchmark recovers from early flesh wounds to end the day flat Ordinary Aussies ‘outraged’ over changes to super that will never, ever affect them The market has...

The ASX climbed 0.4% today after investors threatened it with a stick Mt Monger (ASX:MTM) wins the day by securing funding for it’s Canadian REE play New consumer survey suggests 42% of shoppers might be dumber than previously feared   Au...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX fell today because US data gave Wall Street the willies on Friday A month’s worth of shipping data shows coal shipments to China are on the rise Qantas celebrates last week’s $1bn profit by slashing regional services. Again   Toda...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

The ASX recovered from an early stumble to finish the day up-ish Meta wants you to pay $12 a month for the privilege of being a captive audience Some Big Names have had shockers as earnings relentlessly keep rolling in   The benchmark has...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX 200 climbs about 0.8% on a happier day than yesterday Unemployment jump to 3.7% in January eases concern over future rate rise severity NSW Government’s coal policy kicks miners square in the cokers   Good afternoon, and welcome to th...

Genetic Technologies (ASX:GTG) has announced the publication of a new research paper in the peer-reviewed journal Breast Cancer Research and Treatment.

ASX health stocks fall 1.75% for the past five days Several companies announce successful capital raises Healius drops 15% in the past five days as H1 FY23 results disappoint Healthcare and life sciences expert Scott Power, who has been a...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

ASX slumps even lower after lunch to end the day down around 0.5% China’s demands for the return of “weather balloon” debris met with hearty Pentagon chuckles Terramin’s bid to reopen a sub-winery mine shut down by the SA government   It’...

Genetic Technologies (ASX:GTG) has announced that it has entered into definitive agreements with several institutional investors for the purchase and sale of American Depositary Shares to raise approximately US$5 million.

Psychedelic drugs remain the talk of an otherwise depressed market today Newmont bid for Newcrest helps drive Materials sector higher ASX benchmark limps home to be down 0.25% at the end of a gloomy Monday   It’s not exactly been a stella...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Qantas boss Alan Joyce says “sorry we suck” to an angry Australia Mortgage holders are bricking it as fixed interest rate periods end Spacetalk backs up yesterday’s gains with another massive day at the market. It’s the end of the day at...

Genetic Technologies (GTG) launches a new cancer risk assessment test designed to evaluate a woman’s risk of developing breast or ovarian cancer The “world-first” test combines GTG’s GeneType platform with other clinical risk factors to...

03 Feb 2023 - A snapshot of the stocks on the move featuring Liontown Resources (ASX:LTR), Genetic Technologies (ASX: GTG) and Southern Hemisphere Mining (ASX:SUH).

This content is created by Smallcaps Authors. [Author : Filip Karinja] A ground-breaking comprehensive risk assessment test is set to be introduced by Genetic Technologies (ASX: GTG) to assesses the likelihood that a woman will develop br...

ShareCafeASX 0.37% higher at noon after S&P 500 hits highest level in 5 months by Peter Milios   At noon, the S&P/ASX 200 is 0.37 per cent higher at 7,539.60. Coal miners are facing pressure as coal prices decrease, with Whitehaven...

ShareCafeStocks of the Hour: LTR, GTG, SUH                    Liontown Resources (ASX:LTR) announced that their Open pit mining operations have commenced at their Kathleen Valley lithium project in WA. In response, Liontown’s Managing...

Genetic Technologies (ASX:GTG) rose over 30% this morning after announcing an imminent launch of the world’s first comprehensive risk test for breast and ovarian cancer. The Risk Assessment Test will be able to evaluate a woman’s risk of de...

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Genetic Technologies (ASX:GTG) has announced that it will form a strategic alliance with QIAGEN, a global leader in molecular testing with operations in 35 countries.